Under the Radar Cannabis Opportunity

HENDERSON, NV / ACCESSWIRE / March 26, 2019 / According to Motley Fool, "Aurora Cannabis, Canopy Growth, and Tilray combined made less than $150 million in the last quarter, yet all three marijuana stocks have market caps of at least $6.7 billion, with Canopy's market cap a whopping $16 billion. We're talking about stratospheric price-to-sales (P/S) ratios for all three stocks."

This means investors looking for opportunities with upside in the cannabis space may want to branch out and find more under-the-radar opportunities.

Looking for under-the-radar cannabis investments, we found CleanSpark, Inc. (CLSK). The company is one of the US's top microgrid solutions according to Navigant Research, who added them to their top 10 in 2018. CLSK may be one of the biggest beneficiaries of the cannabis boom because they have created a solution for the cannabis industry that can help growers save as much as 82% on electricity costs. According to their latest press release, the company is focusing its marketing efforts on the largest users in the cannabis market - the agricultural (grow) facilities. This can serve as a strong potential source of revenues in the coming years. The company hopes to get its first contract soon in 2019.

Today we are highlighting: CleanSpark, Inc. (CLSK), Aurora Cannabis, Inc. (ACB), Tilray, Inc. (TLRY), Cronos Group, Inc. (CRON) and Terra Tech Corp. (TRTC).

CleanSpark, Inc. (CLSK) (Market Cap: $143.972M, Share Price: $3.36) has made deals across the board including a $900k contract to install a CLSK microgrid at a U.S. Marine Corps Base, as well as an $18.3 million deal with NYSE company MAC. CLSK also just closed a $5 million round of funding, recently completed the acquisition of Pioneer Power Solutions, Inc., which is expected to add $3.6 million in gross sales to CLSK's bottom line during early 2019 alone, and is working on an up listing.

Research CLSK today.

Aurora Cannabis, Inc. (ACB) (Market Cap: $9.371B; Share Price: $9.25) reported that it had agreed to acquire 51% stake in Portuguese company, Gaia Pharma Ltd., at an undisclosed sum. The company is planning to establish a medical cannabis production facility along with other derivative products as the company expands its reach to Europe. The company, which was granted permission to build an EU GMP-compliant cannabis cultivation facility by the Portuguese Health Ministry, will be renamed Aurora Portugal Lda. Construction of the new facility will be carried out in phases with the first expected to be completed by the third calendar quarter of 2020. The first phase is expected to result in production capacity of about 2,000 kg a year, growing to 4,000 kg a year once the second phase is completed.

Tilray, Inc. (TLRY) (Market Cap: $6.495B; Share Price: $67.78) acquired Manitoba Harvest from Compass Group Diversified Holdings (CODI). Under the terms of the Agreement, Tilray has acquired Manitoba Harvest on a cash and debt-free basis, for an aggregate maximum purchase price, including cash and class 2 Common Stock in the capital of Tilray ("Tilray Shares"), of C$419 million pending the achievement of certain milestones after the closing of the Transaction. Founded in 1998, Manitoba Harvest is the world’s largest hemp food manufacturer and a leader in the natural foods industry.

Cronos Group, Inc. (CRON) (Market Cap: $3.683B; Share Price: $20.53) announced in early December that it had entered into a subscription agreement with Altria Group, Inc., one of the leading tobacco brands in the world, pursuant to which Altria agreed to make an approximately C$2.4 billion equity investment in Cronos Group on a private placement basis in exchange for common shares in the capital of the Company . Altria will also receive Warrants of Cronos Group (the "Warrants"), that if fully exercised, would provide the company with an additional approximately C$1.4 billion of proceeds. The Shares issuable to Altria will result in Altria holding an approximately 45% ownership interest in Cronos Group (calculated on a non-diluted basis) and exercise of the Warrants would result in incremental ownership of 10% for a total potential ownership position of 55%. In Feb 2019, shareholders of Cronos overwhelmingly approved the strategic investment agreement with Altria Group, Inc.